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Abstract. The growing interest in the use of non-thermal, atmospheric pressure gas 
plasmas for decontamination purposes has resulted in a multiplicity of plasma-
generating devices. There is currently no universally approved method of comparing the 
biocidal performance of such devices and in the work described here spores of the Gram 
positive bacterium Bacillus subtilis (ATCC 6633) are proposed as a suitable reference 
biological agent. In order to achieve consistency in the form in which the biological 
agent in question is presented to the plasma, a polycarbonate membrane loaded with a 
monolayer of spores is proposed. The advantages of the proposed protocol are evaluated 
by comparing inactivation tests in which an alternative microorganism (methicillin 
resistant Staphylococcus aureus - MRSA) and the widely-used sample preparation 
technique of directly pipetting cell suspensions onto membranes are employed. In all 
cases, inactivation tests with either UV irradiation or plasma exposure were more 
reproducible when the proposed protocol was followed.   
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1. Introduction 
Interest in the use of non-thermal, atmospheric pressure gas plasmas for inactivating 
micro-organisms has grown rapidly in recent years [1,2,3]. The majority of such 
applications are related to food [4,5,6] and medicine [7,8,9] but are by no means 
restricted solely to these. Over this period of time, a variety of plasma-generating 
devices has been described in the scientific literature [10,11,12] and numerous tests to 
inactivate a wide range of micro-organisms have been conducted. This has led to the 
generation of a large data resource which could in principle serve in the design of gas 
plasma-based disinfection processes. However, what has remained elusive is a method 
of rigorously comparing the biocidal performance of different plasma devices. Even 
determining the true biocidal potential of plasma-generating devices of apparently 
identical configuration is not straightforward. This can be illustrated with reference to a 
couple of examples. In the first of these, Xingmin et al. [13] and Miao and Yun [14] 
using direct barrier discharges (DBDs) which were produced using similar reactor 
configurations, investigated the inactivation of E. coli. Employing similar sample 
preparation methods, the former achieved a single log reduction in viability at a 
measured energy input of 50 J cm-2, whilst the latter achieved the same result with the 
much reduced energy input of 4 J cm-2. In the case of inactivation of Staphylococcus 
aureus, also using DBDs, Xingmin et al. [13] achieved a single log reduction at an 
energy expenditure of just under 6 J cm-2, whereas Sun et al [ 15 ] required 
approximately 4.2 J cm-2, and Ma et al. [16] only 1 J cm-2.  
That the results from these studies are carefully obtained and valid in their own right 
is not contested here. Rather, the point being made is that it is difficult to compare 
results from different studies. It is almost certain that small differences in the operation 
 3
of the devices would have had an influence on the composition of the plasma and this 
would have contributed to some extent to the disparity in the results of the examples 
cited above. Achieving stable and quantifiable plasma operation is obviously desirable, 
and in a recent study Pavlovich et al. [17] put forward procedures designed to achieve 
this. This is an important aspect of experimentation with gas plasmas and one that until 
recently has not been given due attention. Another welcome initiative in this direction is 
that undertaken by the “Plasma Sources for Biomedical Applications” workgroup of the 
European COST action MP1101 “Biomedical Applications of Atmospheric Pressure 
Plasma Technology” [18], which have been working on the design and characterisation 
of a reference plasma source.   
 Notwithstanding such compositional differences, the other major factor 
contributing to the discrepancies in the data mentioned above arises from differences in 
the physical and physiological state of the bacteria presented to the plasmas. Evidence 
for the importance of such factors comes from a variety of previous studies. The life 
cycle of most micro-organisms comprises four phases; the lag phase, the exponential or 
log phase, the stationary phase and the death phase. Due to the expression of specific 
stress response genes, most bacteria possess their highest resistance against external 
stresses during the stationary phase [19]. That this also holds true in the case of plasma 
treatment was demonstrated by Yu et al. [20], who reported differences in the 
inactivation rate constants for E. coli at mid-log, late log and stationary phases of 
growth. 
Even when different research groups employ the same species of micro-organisms, 
the differences that exist between strains of that species can result in wide variations in 
responses to specific external stresses and this can lead to apparent discrepancies in the 
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data obtained similar to those illustrated above. This was demonstrated, for example, in 
the case of the UV irradiation of different strains of Bacillus pumilus [21] where 
differences in UV resistance of up to and in excess of 300 times that of the reference 
strain were exhibited by environmental isolates. Similarly, Bayliak et al. [22] found 
differences in the resistance of different strains of Saccharomyces cerevisiae to 
hydrogen peroxide, whilst more recently, Kossakowska et al. [ 23 ] documented 
differences in the responses of Staphylococcus aureus strains to oxidative stress. 
Although the different susceptibility of strains and even mutants can be exploited to 
gain insights into plasma inactivation mechanisms [24], these differences indicate that 
for a meaningful comparison to be made, trials should be performed with not only the 
same species but also with the same strain.  
Another important factor in determining microbial survival is the physical state in 
which the organisms are presented to the gas plasma. The nature of the substrate itself 
can have a major impact on microbial survival. This was demonstrated by Noriega et al. 
[25] who found that Listeria innocua survived the effects of plasma treatment better 
when applied to the skin of chicken than on chicken flesh.  This was attributed to 
differences in surface topography; chicken skin is characterised by the existence of 
feather follicles inside which the bacteria are able to avoid the lethal effects of the 
plasma, whereas bacteria on the surface of the chicken flesh are more exposed to the 
chemical species present in the gas plasma. However, even when identical substrates are 
employed the spatial arrangements of the cells on the substrate can also affect survival. 
For E. coli, Yu et al. [20] observed an approximate 20-fold reduction in the inactivation 
rate constant as the surface cell concentration was increased from 107 to 1011.   
 5
Based on the above considerations, the objective of the present study is to propose a 
biological protocol for assessing the biocidal efficacy of gas plasma devices so as to 
enable meaningful comparisons to be made between them. Spores of the Gram positive 
bacterium Bacillus subtilis (ATCC 6633) are proposed as the reference biological agent 
and to achieve consistency in the form in which the biological agent in question is 
presented to the plasma, a polycarbonate membrane loaded with a monolayer of spores 
is proposed. The advantages of the proposed protocol are evaluated by comparing 
inactivation tests in which an alternative candidate organism (methicillin resistant 
Staphylococcus aureus - MRSA) and the widely-used sample preparation technique of 
pipetting cells suspensions directly onto membranes were employed. Besides plasma 
treatment, irradiation of bacteria-laden membranes with UV light at a wavelength of 
254 nm was also conducted in order to facilitate interpretation of the results on the basis 
that emission from simple UV sources is intrinsically reproducible and that it remains 
stable over time.  
2. Materials and methods 
2.1. Preparation of Bacillus subtilis spore stock 
The method employed to generate spores was essentially that described by Harnulv 
and Syngg [26] with minor variations to their procedures. Nutrient agar (Oxoid Ltd, 
Basingstoke, Berks) slopes of Bacillus subtilis (NCIMB 8054/ATCC 6633) were 
prepared from a lyophilised culture obtained from the National Collection of Industrial 
and Marine Bacteria (Aberdeen, UK.) using standard microbiological procedures. A 
loopful of cells from one such slope was used to inoculate 100 ml of Nutrient Broth 
(Oxoid) in a 500 ml Erlenmeyer flask which was then incubated at 37 °C for 24 hours in 
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a rotary shaker at 130 rpm. Aliquots (200 µL) of this culture were pipetted onto the 
surface of 140 mm diameter petri dishes containing sporulation agar formulated as 
described by Harnulv and Syngg [26], which were then incubated at 30 °C for 14 days.  
After this period of time, de-ionised water (5 mL) was gently pipetted onto the surface 
of the agar and the bacterial growth was gently suspended into the water using a sterile 
loop. The accumulated spore suspensions from 5 petri dishes were then combined and 
centrifuged at 8,000 x g for 20 minutes using a model Z383K centrifuge (Hermle 
Labortechnik GmbH, Wehningen, Germany). The supernatant was then poured off and 
10 mL of de-ionised water were pipetted into the centrifuge tube. The tube was then 
vigorously agitated to resuspend the pellet on a vortex mixer. This procedure of 
centrifugation and washing was repeated a further two times. The suspension was then 
transferred to a thin walled glass vial of 82 mm height and 27 mm dia. (Ref. 14823562, 
Fisher Scientific UK Ltd, Loughborough, UK). The vial was then placed in a water bath 
containing 20 L of water at ambient temperature (Clifton NE2-22D, Fisher Scientific 
UK Ltd, Loughborough, UK) and the temperature was of the bath was increased to 70 
°C at a rate of 2°C/min. Once the water bath had reached the set point (70 °C), it was 
maintained at this temperature for 30 minutes. The vial containing the spore suspension 
was removed from the water bath and stored at 4oC until needed. The spore 
concentration was measured to be 1.5 x 1010 spores per ml. 
2.2. Preparation of Methicillin Resistant Staphylococcus aureus 
A clinical isolate of MRSA (PM64) was kindly donated by Dr Julie Morrissey of the 
Department of Genetics, University of Leicester, UK. The culture was maintained on 
Luria Agar slopes and stored in a refrigerator for no more than one month before sub-
culturing. 
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In order to prepare cultures for experiments, a loopful of cells from a slope were 
used to inoculate 100 ml of Luria Broth in a 500 ml Erlenmeyer flask which was 
incubated on a rotary shaker at 37 °C and 130 rpm for 17 hours. Following this a 1 mL 
aliquot of this culture was used to inoculate a fresh flask of Luria broth incubated as 
described above for 4 hours in order to generate a mid-log phase culture (9.8x108 
CFU/ml). A 10 mL aliquot of this culture was transferred to a sterile centrifuge tube and 
centrifuged at 1750 x g for 30 minutes (Heraeus Labofuge 400R, Fisher Scientific UK 
Ltd, Loughborough, UK). The supernatant was poured off and 10ml of sterile Ringer’s 
solution (Oxoid) was added to the tube. After vortexing to resuspend the pellet, the 
broth was centrifuged under identical conditions to those described above a further two 
times to yield a suspension of MRSA for deposition on membranes.   
2.3. Bacterial Deposition on Membranes  
2.3.1. Filtration – Spores of B. subtilis 
The spore stock suspension generated as described above was highly concentrated, 
and it was found necessary to dilute it in two stages in order to obtain a homogeneous 
suspension of disaggregated spores. To do this 100 µl of spore stock was added to 900 
µL of Ringers solution (Oxoid) in an Eppendorf tube which was then vigorously 
agitated using a vortex mixer. A 90 µl aliquot of this suspension was added to 10 mL of 
Ringers solution. This suspension was then drawn into a 10 mL syringe which was 
mounted onto an autoclave-sterilised Swinnex filter holder with a Lauer fitting 
(SX0002500, Millipore (U.K.) Limited, Watford, UK). A 25mm diameter Nucleopore 
track-etched polycarbonate hydrophilic membrane with a pore size of 0.2 µm (GE 
Healthcare Life Sciences, Little Chalfont, UK) was loaded into the filter holder prior to 
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autoclaving. The assembly was inserted through a rubber bung which was used to seal a 
heavy-walled glass conical flask of 2 L capacity and fitted with a side arm which was 
connected to a vacuum pump (Model N810FF-18, KNF Neuberger Inc, Trenton, USA). 
The arrangement is similar to that used by Bayliss et al [28] and a schematic is shown in 
Figure 1. Filtration was conducted at 66kPa. Following this, the membrane holder was 
removed from the system and disassembled to permit the membrane to be carefully 
removed using fine-tipped forceps and then placed in an open petri dish to dry. 
2.3.2. Filtration - MRSA 
The procedure employed with MRSA was identical to that described above for B. 
subtilis with the exception that 220 µL of the working suspension was pipetted into 
10ml of Ringers solution for filtration. 
2.3.3. Pipetting – B. subtilis 
An aliquot (98 µL) of the working spore stock suspension was pipetted directly onto 
a sterile membrane placed in a petri dish. The petri dish was then placed on a hot plate 
(11-102-50SH Fisher Scientific UK Ltd, Loughborough, UK) at 40° C until all the 
liquid had evaporated. 
2.3.4. Pipetting - MRSA 
The procedure outlined above was followed with the exception that 270 µL of the 
working suspension was pipetted onto each membrane. 
2.4. Recovery of cells from membranes 
To recover cells, the micro-organism laden membranes were transferred to sterile 
glass Universal bottles containing 10ml Ringers solution and five 3 mm glass Ballotini 
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beads (VWR International Ltd, Lutterworth, UK). The contents of the bottle were then 
vigorously agitated for 45 seconds using a vortex mixer. Serial dilutions in Ringers 
solution were carried out prior to plating 100 µL aliquots onto LB agar plates and 
incubating overnight at 37° C prior to counting the colonies formed. Counts were 
performed in triplicate. 
2.5. Plasma treatment of membranes 
A custom-built surface dielectric barrier discharge (DBD) plasma device was 
fabricated to treat the membranes (Figure 2). The system is closed and operates in 
ambient air. The plasma source consists of a 1.6mm thick dielectric substrate (glass-
reinforced epoxy FR-4) with a powered copper plane on one side and a ground mesh-
like copper electrode on the other. The membranes were kept at a distance of 9mm from 
the plasma source. The plasma source was powered by an in-house built half-bridge 
resonant power supply that delivered a sinusoidal voltage of 5.25kV at 20.5kHz. The 
applied voltage was modulated by a square signal of 2Hz with a duty cycle of 5%, i.e. 
plasma on-time of 25ms every half second. The time averaged power delivered to the 
plasma was 850mW, as determined by the analysis of the charge vs voltage (Q-V) 
Lissajous diagram [27]. The bacteria-laden membranes were transferred from petri 
dishes to the plasma device sample holder using sterile thin tipped forceps making sure 
to only contact the outer edge of the membrane where no cells were present.  
The maximum temperature reached during a plasma treatment was monitored using 
a K-type thermocouple (307P, CIE test instruments, Kolkata, IN) placed 2mm below the 
plasma source. The plasma system was left to cool down to room temperature after each 
run. The temperature in the system increased by 7 degrees above ambient temperature 
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after 1h of continuous operation, but for the much shorter treatments employed for the 
MRSA inactivation tests, the increase in temperature was less than 2°C above the room 
temperature.   
2.6. UV treatment of membranes 
Membranes were placed inside open petri dishes for UV treatment. The petri dish 
was placed on a platform which rotated at 4 rpm directly underneath a 5W mercury 
vapour UV source (TUV 5W-F, Philips Belgium N.V., Brussels, BE). The rotating 
platform served to ensure even treatment of all areas of the membrane particularly when 
a stainless steel mesh (see below) was employed to reduce the UV intensity as 
otherwise this might have resulted in shadowing effects. The lamp was housed in a 
fixture which had a 2x9cm aperture. The distance between the source and the base of 
the petri dish being 210 mm. For irradiating MRSA-laden membranes a tightly woven 
stainless steel mesh was placed immediately beneath the aperture to reduce the UV 
intensity. This was measured using a radiometer (Model UVX, UVP Ltd., Cambridge, 
UK). The UV intensity for irradiating B. subtilis laden membranes was 25.01 µW/cm,2 
whilst that for MRSA was 1.16 µW/cm.2 
2.7. Sample preparation for scanning electron microscope (SEM) imaging 
The procedure for preparing MRSA laden membranes for SEM imaging was 
identical to that described by Bayliss et al. [28]. Following the washing and dehydrating 
procedure, samples were coated with gold palladium using a SC7640 sputter-coater 
(Quorum Technologies Ltd, Lewes, UK) for 90s at 25mA. The SEM images were 
obtained using a TM3030 microscope (Hitachi High-Technologies Europe GmbH, 
Krefeld, Germany).  
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For B. subtilis laden membrane, the protocol was modified to avoid washing off 
spores during the fixation and dehydrating procedure. In particular, the first 1% 
gluteraldehyde and the ethanol washing stages were omitted and samples were left to 
dry overnight to avoid having to pour off excess solutions which had a tendency to 
remove “rafts” of spores.  
3. Results and discussion 
3.1. Reference biological agent 
Spores of the Gram positive bacterium Bacillus subtilis (ATCC 6633) are proposed 
as the reference biological agent. The advantages of using this particular bacterium are 
that it is non-pathogenic and therefore it can be widely used without high biological 
safety requirements, and once produced, spores stocks can be kept for many years with 
only a negligible reduction in viability. Although a new stock was prepared for this 
work in order to document precisely all the preparation steps, we have spores stocks in 
the lab that were prepared almost a decade ago and have over this period exhibited 
negligible loss of viability. This is hardly surprising given the intrinsic resistance of 
spores to radiation, heat and chemicals [29]. In fact, spores of the genus Bacillus (albeit 
B. sphaericus rather than B. subtilis), have been revived after more than 25 million 
years [30].  
Using spores from a stock obviates the need to produce micro-organisms at a 
particular phase of growth for each experimental trial, which reduces variability 
between experiments and speeds up experimental procedures. Since spores are likely to 
be present in most practical applications and they are more resistant to external stresses 
 12
than are vegetative bacteria, the use of spores would also add relevance to the 
inactivation results obtained in the proposed reference test.  
Notwithstanding such considerations, it is important to ensure that the conditions 
under which the spores are generated is consistent as otherwise this will affect their 
resistance to gas plasma treatment [31]. This fact explains the exceedingly detailed 
procedures described under Materials and Methods for generating spore stocks and why 
it is necessary to adhere to them. 
As a means of assessing the benefits of using B. subtilis spores as a reference 
biological micro-organism, inactivation tests with another bacterium have also been 
conducted for comparison. Methicillin resistant Staphylococcus aureus (MRSA PM64) 
was used in this case for its clinical relevance. Experiments involving MRSA required a 
Class II biological laboratory and to minimise the sources of variability between 
experiments with spores of B. subtilis and those with MRSA, all the experiments 
reported in this work were performed in the same Class II facility. Besides the 
additional biological safety demands and the longer preparation time required to prepare 
mid-log phase bacteria for each separate experiment, MRSA is also more liable to form 
cell clusters. As colonies formed from cell agglomerates cannot be differentiated from 
those originating from single cells, clustering is a source of variability that affects plate 
counts. Furthermore, cell clustering also affects the consistency in which a monolayer 
of cells can be deposited (see section  3.2 below). 
Although the plasma gas temperature can be actively controlled [32], most plasma 
treatments reported in the literature are conducted at room temperature without tight 
control over the temperature at which the cells are being treated. The resistance of 
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vegetative cells to external stressors, however, can be quite sensitive to small 
temperature variations, and only a few degrees difference can drastically change the cell 
response. For example, it has been documented that the antibiotic resistance of MRSA 
can change significantly depending on the temperature (30-37°C) at which this is 
measured [33,34]. Therefore, the use of a less temperature sensitive biological agent, 
such as spores of B. subtilis, provides a more robust reference test and will enable 
meaningful comparisons between plasma devices in different labs without the need to 
exercise tight control over temperature during cultivation and subsequent processing. 
3.2. Deposition method and recovery rates 
The physical state in which the micro-organisms are presented to the gas plasma 
influences their resistance to the treatment and therefore, in order to achieve meaningful 
comparisons between plasma devices it is important that not only the same micro-
organism be used, but also that the micro-organisms are presented in a consistent and 
repeatable form. To accomplish this, it is proposed that membranes loaded with a 
monolayer of bacteria are used. The membranes provide a consistent substrate for the 
deposition and recovery of micro-organisms and by depositing a monolayer of micro-
organisms, variability and problems associated with shadowing and stacking of bacteria 
are overcome [28]. Drying of membranes post deposition should be slow, i.e. at room 
temperature and in the absence of forced convection to avoid spores being transported 
across the membranes by the evaporating water film as witnessed by Bayliss et al[28]. 
The filtration protocol described in section  2.3 was selected to deposit the number of 
B. subtilis spores and of MRSA bacteria required to create a monolayer on the 
membranes. The pipetting protocols were designed to deliver the same number of cells 
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per unit area of membrane as for filtration. In the calculations conducted, account was 
made of the effective area of the membrane upon which the cells are deposited. This was 
because it was observed that in the case of filtration, contact of the membrane with the 
underlying supporting rings reduced the available area where cell could be deposited. 
The dimensions of these rings depend on the specific membrane holder used. These 
concentric rings formed on a B. subtilis spore-laden membrane are shown in Figure 3a-
b. Most significantly, the distribution of spores across the entire membrane is fairly 
uniform. This is shown in the SEM images of Figure 3c-f taken at four different 
locations across the same membrane. Two of these images where taken at regions which 
displayed a relatively high spore concentration (Figure 3c-d) and two at regions with a 
relatively low spore concentration (Figure 3e-f). These images clearly show that 
stacking of spores did not occur. 
Figure 4 shows a comparison between the two deposition methods considered in this 
study, namely the proposed membrane filtering technique and the widely-used method 
of pipetting cell suspensions directly onto membranes. Whereas pipetting cell 
suspensions onto membranes results in large variations in the way cells are deposited 
across the same membrane (compare Figure 4a-4b for spores of B. subtilis and Figure 
4d-4e for MRSA), the proposed filtering technique deposits cells uniformly across the 
whole membrane (with the exception of the ring regions as described above where no 
cells are deposited – see Figure 3). The stacking and the extent of the unpopulated 
regions observed in the pipette-deposited membranes appear to be random as these are 
driven by surface tension forces acting during the drying process. It is worth mentioning 
that even when the density of cells in the pipetted solution is lowered, agglomeration 
and stacking of cells persist. This random distribution of cells affects the inactivation 
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tests because bacteria shielded in regions where stacking occurs will be more resistant 
to plasma than bacteria directly exposed to the plasma in regions where few cells have 
been deposited. Therefore, pipetting would inevitably contribute to variability in the 
results of inactivation tests, preventing meaningful comparison between different 
plasma sources. 
Besides sample preparation for inactivation tests, it is also imperative to assess the 
recovery of cells from the membranes following the exposure to the biocidal agent. 
Figure 5 shows the percentage of cells recovered from membranes laden with B. subtilis 
and MRSA using the proposed filtering technique and the conventional pipetting 
method. The percentage of cells recovered is dependent both upon the identity of the 
micro-organism and the deposition method employed (Figure 5), and in the case of 
pipetted MRSA only 9% of the deposited bacteria was recovered whereas in the case of 
pipetted B. subtilis 76% of the spores were retrieved. The very low MRSA recovery for 
pipetted samples is attributed to the tendency of MRSA bacteria to form clusters which, 
as explained above, in relation to plate counting will result in an underestimation of the 
actual number of viable cells. Although a low recovery is not a problem in itself, small 
variations in the low recovery rates translate into large relative errors (45% for the 
recovery of pipetted MRSA) and these would introduce large uncertainties in the 
inactivation tests.  
It is worth noting that for both micro-organisms, recovery from filtered samples 
results in smaller error bars, i.e. better reproducibility, than for pipetted samples. This 
improved consistency in the recovery of filtered samples is attributed to the more 
reproducible deposition of cells across the membrane and in the reduction in the number 
of cell clusters present when the filtering technique is used. Although recovery of B. 
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subtilis from filtered membranes is less effective than from pipetted membranes 
(probably due to some spores becoming trapped in the membrane after the pressure-
driven deposition), it is evident that the smallest error bars in the recovery data (3%) 
were obtained for the proposed protocol of filter-deposited B. subtilis spores.   
3.3. UV inactivation of B. subtilis and MRSA 
Inactivation tests of B. subtilis and MRSA, both filtered and pipetted, were 
conducted by irradiating bacteria-laden membranes with UV light at 254nm. The goal 
of these tests was to demonstrate that more repeatable results are obtained when the 
proposed protocol (i.e. filtered membranes with B. subtilis spores) is used.  
Figure 6 shows the results of these inactivation tests. Each time point on the 
coloured curves was generated from three samples with counts being themselves 
conducted in triplicate (i.e. a total of 9 plate counts per data point on each curve). Each 
coloured curve was generated from experiments conducted on separate days and on 
each day a fresh stock of bacteria was prepared. The solid black line shown in the figure 
represents the average of all the experiments, and therefore each point is the average of 
27 independent readings. Error bars represent the standard deviation from the mean. For 
both micro-organisms considered in this study, inactivation results determined from 
filtered samples are more reproducible than results obtained using pipetted samples 
(compare Figure 6a-6c for B. subtilis and Figure 6b-6d for MRSA). 
Unsurprisingly, it is evident that micro-organisms filtered onto membranes can be 
inactivated more readily than those that were pipetted. For the present conditions, a 
further 1-log reduction is obtained for the longest treatment times (compare Figure 6a-
6c for B. subtilis and Figure 6b-6d for MRSA). The lower inactivation efficacy against 
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pipetted micro-organism is attributed to the protective shielding that occurs in regions 
where stacking takes place in pipette-prepared membranes (see Figure 4b and 4e).   
When comparing the inactivation curve of B. subtilis spores with that of MRSA, it is 
evident that the B. subtilis spores are more resistant to UV irradiation, requiring ~15 
times higher UV dosage to achieve the same log reduction. It is also noted that for both, 
the pipetting technique and the filtering method, inactivation of B. subtilis spores were 
found to be more reproducible than their MRSA counterparts (compare Figure 6a-6b for 
filtered cells and Figure 6c-6d for pipetted cells).  
In summary, of the four sample preparation methods considered in Figure 6, B. 
subtilis spores filtered onto membranes (Figure 6a) provides the most reproducible 
results.  
3.4. Plasma inactivation of B. subtilis and MRSA 
Inactivation tests of B. subtilis and MRSA, both filtered and pipetted, were also 
conducted by exposing bacteria-laden membranes to an atmospheric pressure air DBD 
discharge. As for the UV inactivation experiments, the goal of these tests was to 
demonstrate that more repeatable results are obtained when the proposed protocol is 
used. 
Figure 7 shows the results of these inactivation tests. As before, each time point on 
the coloured curves was generated from three samples with counts being themselves 
conducted in triplicate. Each coloured curve was generated from experiments conducted 
on separate days and on each day a fresh stock of bacteria was prepared. The solid black 
line shown in the figure represents the average of all the experiments and the error bars 
represent the standard deviation. For both micro-organisms considered in this study, 
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inactivation results determined from filtered samples are more reproducible than results 
from pipetted samples (compare Figure 7a-7c for B. subtilis and Figure 7b-7d for 
MRSA). Of the four sample preparation methods considered in the plasma inactivation 
tests shown in Figure 7, B. subtilis spores filtered onto membranes (Figure 7a) yielded 
the most reproducible results.  
It is interesting to note that the inactivation kinetics of filtered B. subtilis spores 
undergoing UV irradiation (Figure 6a) or plasma exposure (Figure 7a) are distinct from 
one another. The UV inactivation kinetics show a bi-phasic characteristic whereas the 
plasma inactivation curve shows only a log-linear phase. This suggests that a different 
inactivation mechanism is at play when the cells are exposed to plasma. The tailing of 
the inactivation curve has been attributed to a number of factors including an intrinsic 
lack of precision in the enumeration of low concentration of survivors, the presence of 
cell aggregates, heterogeneity of the population of micro-organisms, heterogeneity of 
treatment, and shielding from direct exposure to the biocidal agent. It is possible that the 
tailing phase in the plasma-treated samples is not observed at the doses considered in 
this work because plasma exposure comprises diffusible gaseous agents that can exhibit 
lethality even against stacks of cells for which UV irradiation is ineffective.  
Consideration needs to be given to the selection of a ‘biological target’ that is 
compatible with the type of plasma generating device undergoing evaluation. For a 
plasma jet with an effective area of a few mm2, for example, use of membranes of 
dimensions as specified here would be appropriate if the jet were mounted on a 2D 
moving stage to ensure even plasma treatment across the membrane [35]. Alternatively, 
the procedures described here could be applied to membranes of smaller diameter. In 
the same way, larger membranes could also be employed if this was warranted by the 
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dimensions of the plasma-generating device undergoing evaluation.  Whilst treatment 
of bacteria-laden membranes with such jets was not undertaken in this study, previous 
investigation has revealed that some detachment and loss of loosely adherent bacteria 
can occur [28] and therefore it would be essential under such circumstances to conduct 
appropriate control experiments in order to quantify such effects.  
4. Conclusions 
Spores of the Gram positive bacterium Bacillus subtilis (ATCC 6633) are proposed 
as a suitable reference biological agent for arriving at a valid assessment of the biocidal 
potential of gas plasma-generating devices The advantages of using this particular 
bacterium are that it is non-pathogenic, and once produced, spores stocks can be kept 
for many years with only a negligible reduction in viability. Using spores from a stock 
obviates the need to produce micro-organisms at a particular phase of growth for each 
experimental trial, which reduces variability between experiments and speeds up the 
experimental procedures. In addition, consistency in the form in which the biological 
agent is presented to the plasma was achieved by filtering under vacuum spore 
suspensions of known concentration through a polycarbonate membrane. This sample 
preparation technique was demonstrated to repeatedly minimise random cell stacking, a 
known source of variability in experimental tests.   
To demonstrate the advantages of the proposed protocol, we conducted inactivation 
tests using another micro-organism (methicillin resistant Staphylococcus aureus - 
MRSA) combined with the widely used sample preparation technique of pipetting cells 
suspensions onto membranes. Micro-organism laden membranes were exposed to either 
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UV light at 254 nm or atmospheric pressure air plasma. In all cases, the proposed 
protocol required much shorter preparation time and resulted in greater reproducibility. 
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FIGURE CAPTIONS 
Figure 1. Schematic of the arrangement used to filter-deposit cells onto membranes. 
Figure 2. (a) Schematic of the plasma device used to treat the spore/cell laden 
membranes. The membrane is clamped by an O-ring onto the base of the 
device. (b) View of the patterned ground electrode. 
Figure 3. SEM images of a Bacillus subtilis spore laden membrane. (a) Low 
magnification image showing concentric rings where spores are not 
deposited due to the geometric configuration of the membrane holder used 
during the filtration. (b) Close up view at one of the rings. (c-d) Close up 
view at two regions with high concentration of spores. (e-f) Close up view at 
two regions with low concentration of spores. 
Figure 4. SEM images of membranes laden with (a-c) Bacillus subtilis and (d-e) MRSA. 
(a-b) Two regions of the same B. subtilis pipetted membrane. (d-e) Two 
regions of the same MRSA pipetted membrane. (c) B. subtilis filtered 
membrane. (f) MRSA filtered membrane. 
Figure 5. Cell recovery from B. subtilis and MRSA laden membranes. Error bars 
represent standard deviation based on 4 experimental replicates. 
Figure 6.  Inactivation kinetics of (a) filtered B. subtilis spores, (b) filtered MRSA, (c) 
pipetted B. subtilis spores and (d) pipetted MRSA by 254nm UV irradiation. 
Figure 7. Inactivation curves of (a) filtered B. subtilis spores, (b) filtered MRSA, (c) 
pipetted B. subtilis spores and (d) pipetted MRSA by exposure to air plasma. 
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Figure 1. Schematic of the arrangement used to filter-deposit cells onto membranes. 
 
  
 23
 
 
Figure 2. (a) Schematic of the plasma device used to treat the spore/cell laden membranes. The 
membrane is clamped by an O-ring onto the base of the device. (b) View of the patterned ground 
electrode. 
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Figure 3. SEM images of a Bacillus subtilis spore laden membrane. (a) Low magnification image 
showing concentric rings where spores are not deposited due to the geometric configuration of the 
membrane holder used during the filtration. (b) Close up view at one of the rings. (c-d) Close up view at 
two regions with high concentration of spores. (e-f) Close up view at two regions with low concentration 
of spores. 
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Figure 4. SEM images of membranes laden with (a-c) Bacillus subtilis and (d-e) MRSA. (a-b) Two 
regions of the same B. subtilis pipetted membrane. (d-e) Two regions of the same MRSA pipetted 
membrane. (c) B. subtilis filtered membrane. (f) MRSA filtered membrane.  
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Figure 5. Cell recovery from B. subtilis and MRSA laden membranes. Error bars represent standard 
deviation based on 4 experimental replicates.   
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Figure 6.  Inactivation kinetics of (a) filtered B. subtilis spores, (b) filtered MRSA, (c) pipetted B. 
subtilis spores and (d) pipetted MRSA by 254nm UV irradiation. 
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Figure 7. Inactivation curves of (a) filtered B. subtilis spores, (b) filtered MRSA, (c) pipetted B. subtilis 
spores and (d) pipetted MRSA by exposure to air plasma. 
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